title: The participation of health professionals in a smoking-cessation programme positively influences the smoking cessation advice given to patients.
abstract: This study assessed the degree of smoking cessation advice given by health professionals, before and after their participation in a smoking cessation study using bupropion-sustained release (bupropion SR, Zyban). A total of 690 physicians and nurses who had smoked an average of 10 cigarettes/day over the previous year and were motivated to quit smoking, were randomised in a double-blind manner to receive bupropion SR (days 1-3, 150 mg/day; days 4-49, 150 mg twice daily) or placebo for 7 weeks, with follow-up to week 52. All subjects received regular follow-up and brief motivational support throughout the study. Questions regarding their smoking cessation advice formed part of the study, with the aim of determining whether study participants became more proactive with their smoking cessation advice. A positive shift from baseline to end of study was observed with respect to the advice and support they gave to their smoking patients. These changes were not related to study treatment or current smoking status. An increase in advising patients to quit smoking and in offering cessation counselling was observed. Participation in a smoking-cessation study by physicians and nurses who smoke has a positive effect, regardless of study medication, in smoking cessation advice and counselling given to their patients.
authors.affiliation: National Public Health Institute, Helsinki, Finland. pekka.puska@ktl.fi
authors.forename: P M J
authors.initials: PM
authors.lastname: Puska
authors.forename: M
authors.initials: M
authors.lastname: Barrueco
authors.forename: C
authors.initials: C
authors.lastname: Roussos
authors.forename: A
authors.initials: A
authors.lastname: Hider
authors.forename: S
authors.initials: S
authors.lastname: Hogue
mesh_terms: D016642:Bupropion / Q000008:administration & dosage; D003376:Counseling / Q000592:standards*; D003692:Delayed-Action Preparations; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage; D004311:Double-Blind Method; D005260:Female; D006282:Health Personnel / Q000592:standards*; D006293:Health Promotion / Q000592:standards*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009042:Motivation; D011364:Professional Practice / Q000592:standards*; D011369:Professional-Patient Relations; D016540:Smoking Cessation
chemical_list: D003692:Delayed-Action Preparations; D018765:Dopamine Uptake Inhibitors; D016642:Bupropion